home / stock / gwph / gwph news


GWPH News and Press, GW Pharmaceuticals Plc From 02/03/21

Stock Information

Company Name: GW Pharmaceuticals Plc
Stock Symbol: GWPH
Market: NASDAQ
Website: gwpharm.com

Menu

GWPH GWPH Quote GWPH Short GWPH News GWPH Articles GWPH Message Board
Get GWPH Alerts

News, Short Squeeze, Breakout and More Instantly...

GWPH - Hot Penny Stocks to Watch Today If You Like Marijuana Stocks

Marijuana Stocks Are Heating Up The Stock Market Today We know the exotic nature of certain industries, especially if you’ve become familiar with penny stocks. Some of the unique business models are utilized, ranging from treasure hunting to luxury rail-cars. While those sort of ...

GWPH - Zogenix jumps on positive read through from GW Pharma/Jazz deal

Zogenix (ZGNX) climbing 18% in premarket trading on a positive read through from Jazz Pharmaceuticals'  (JAZZ) $7.2b planned purchase of GW Pharmaceuticals (GWPH).The deal values GWPH at 9.4x EV/consensus 2021 estimated sales and if one applies a similar multiple for Zogenix it gets to a...

GWPH - Jazz Pharmaceuticals Is Buying GW Pharmaceuticals in $7.2 Billion Deal

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is buying GW Pharmaceuticals plc (Nasdaq: GWPH) in a deal valued at $7.2 billion or $6.7 billion net of GW cash. Jazz will acquire GW for $220.00 per American Depositary Share (ADS), in the form of $200.00 in cash and $...

GWPH - Jazz to acquire GW Pharma in cash-and-stock deal valued at $7.2B

Jazz Pharmaceuticals (JAZZ) is trading ~5.3% lower in the premarket after announcing that it has agreed to acquire GW Pharmaceuticals plc (GWPH) for $220.00 per American Depositary Share.The transaction in the form of $200.00 in cash and $20.00 in Jazz ordinary shares repr...

GWPH - Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma Leader

Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma Leader Adds high-growth commercial franchise to Neuroscience portfolio with Epidiolex®, the first and only FDA-approved prescription cannabidiol medicine and a pote...

GWPH - Now Is The Time To Build A National Cannabis Brand (Podcast Transcript)

Talking CBD, hemp, cannabinoids in the health and wellness segment with Smoke Wallin, CEO of Vertical Wellness. Many regulatory headwinds, but near-term hemp and CBD saturation will open up and level off. FDA still captive to pharma industry. Bigger opportunity for natural products in...

GWPH - 3 Marijuana Stocks To Watch Next Week

These 3 Marijuana Stocks Closed The Month With Gains Is now the time to start looking for marijuana stocks to buy . With all the recent commotion about Wall Street, Game Stop, Reddit, and Robin Hood some investors have taken the time to focus on other sectors. Currently, cannabis ...

GWPH - 2 Marijuana Stocks To Watch This Friday For Possible Gains

Will These Marijuana Stocks Pick Up More Market Momentum On January 28th many of the top marijuana stocks to watch saw better gains. Back on the 27th, many cannabis stocks dropped in trading. Prior to this marijuana stocks have had some great momentum to start the new year. Currentl...

GWPH - Now Is The Time To Build A National Cannabis Brand (Podcast)

Talking CBD, hemp, cannabinoids in the health and wellness segment with Smoke Wallin, CEO of Vertical Wellness. Many regulatory headwinds, but near-term hemp and CBD saturation will open up and level off. FDA still captive to pharma industry. Bigger opportunity for natural products in...

GWPH - Cannabis In California Will Boom Into A Powerhouse Opportunity

Cannabis sales are determined by number of dispensaries and the availability to them by proximity. California has no restrictions regarding the number of dispensaries such as Washington State. Growth in cannabis in California will eclipse the entire cannabis industry's current ret...

Previous 10 Next 10